Tadalafil and Workout Performance: The Off-Label Conversation

By Dr. Mark Rosenberg

Tadalafil is being talked about in gyms, podcasts, and online fitness communities as a “pump” enhancer or pre-workout add-on. Some men report better vascularity, fuller muscles during training, and improved endurance. Others are curious but unsure whether this is real physiology or gym-bro hype.

Here is the medically grounded answer: there is a plausible mechanism, but this is an off-label use. Tadalafil is FDA-approved for erectile dysfunction and benign prostatic hyperplasia, not for athletic performance, muscle growth, or bodybuilding. Any use for training performance should be discussed with a physician, especially if you have cardiovascular risk factors or take other medications.

What Tadalafil is Actually Approved For:

Tadalafil is a PDE5 inhibitor. It is best known by the brand name Cialis. FDA-approved indications include erectile dysfunction, symptoms of benign prostatic hyperplasia, and the combination of ED and BPH. Certain tadalafil formulations are also used for pulmonary arterial hypertension under different dosing and labeling.

Using tadalafil to improve workouts, pumps, endurance, or gym performance is not an FDA-approved indication. That does not mean the conversation is imaginary. It means the level of evidence and regulatory review is not the same as it is for ED or BPH (benign prostatic hyperplasia).

The Plausible Mechanism: Nitric oxide, cGMP, and Vasodilation

To understand why weightlifters are interested in tadalafil, you need to understand the nitric oxide pathway.

During sexual stimulation, exercise, or other vascular signaling, the body produces nitric oxide. Nitric oxide increases a messenger molecule called cGMP, which relaxes smooth muscle in blood vessel walls. When blood vessels relax, they widen. That process is called vasodilation.

Tadalafil blocks the enzyme PDE5, which breaks down cGMP. By inhibiting PDE5, tadalafil allows cGMP signaling to last longer in tissues where PDE5 is active. The practical result is improved vasodilation in certain vascular beds.

In the gym, the theory is straightforward: more vasodilation could mean more blood flow to working muscle, which could translate into a stronger “pump,” better nutrient delivery, or improved exercise tolerance. That mechanism is biologically plausible.

But plausible does not mean proven.

What the Actual Exercise Evidence Shows

The human evidence for tadalafil as a performance enhancer is limited and mixed. There are studies showing that PDE5 inhibition can affect endothelial function, blood flow regulation, or exercise physiology in certain populations. There is also evidence that it may not meaningfully improve performance in healthy people under typical exercise conditions. Endothelial cells are the cells that line the inner surface of blood vessels, and release nitric oxide and prostacyclin to relax blood vessels.

One study in men with increased cardiovascular risk found that chronic tadalafil therapy improved endothelial function, measured by flow-mediated dilation. That supports the idea that tadalafil can influence vascular function in people with endothelial dysfunction. However, improved endothelial function is not the same thing as more muscle growth or better gym performance.

In a study looking at anaerobic performance, a single dose of tadalafil did not substantially improve anaerobic performance indices. This is directly relevant to gym claims because many lifting sessions depend heavily on anaerobic output, strength, repeated efforts, and local muscular fatigue.

There is also niche research in skeletal muscle disease and vascular dysfunction. Some preclinical work in dystrophic muscle suggested PDE5 inhibition could reduce contraction- or exercise-related muscle damage, but that does not translate directly to healthy adult lifters. A phase 3 trial in boys with Duchenne muscular dystrophy found tadalafil did not slow ambulatory decline, showing how difficult it is to turn a plausible muscle-blood-flow mechanism into a proven clinical benefit.

There is one small clinical study often cited online suggesting daily tadalafil improved lean mass and endothelial function in non-obese men with mild ED and lower urinary tract symptoms. That finding is interesting, but it should be treated cautiously. It was not a bodybuilding trial, not a hypertrophy program in trained lifters, and not proof that tadalafil directly builds muscle.

So the fair summary is this: tadalafil may improve vascular function in some contexts, and it may subjectively enhance pumps for some men. But there is not strong evidence that it reliably improves strength, hypertrophy, sprint performance, or resistance-training outcomes in healthy lifters.

What Tadalafil Likely Does Not Do

Tadalafil is not an anabolic steroid. It does not directly increase testosterone. It does not directly activate androgen receptors in the way anabolic agents do. It does not replace progressive overload, protein intake, calories, sleep, creatine, or intelligent programming.

It also does not guarantee better performance. A better pump can feel productive, but a pump is not the same thing as mechanical tension, training volume, strength progression, or muscle protein synthesis. For hypertrophy, the core drivers are still progressive resistance training, adequate nutrition, recovery, and consistency.

A lifter could have a great pump and still make no long-term progress. Conversely, a lifter could make excellent progress without using any vasodilating medication.